Jump to content

Draft:Silvia Rouskin

From Wikipedia, the free encyclopedia
  • Comment: For violating Wikipedia's Terms of Use regarding paid editing. The article has been created under various different titles in a failed effort to bypass detection. S0091 (talk) 20:05, 11 August 2024 (UTC)

Prof.
Silvi Rouskin
Born
Other namesSilvia Rouskin
CitizenshipUSA, Bulgaria
AwardsVilcek Prize 2021, Pew Scholar 2024
Academic background
Alma mater
ThesisInvestigating RNA structure and function, transcriptome-wide (2014)
Doctoral advisorJonathan Weissman
Academic work
Discipline
Main interests
Notable worksDMSMaP-seq, DREEM

Silvi Rouskin is a molecular biologist and Assistant Professor of Microbiology at Harvard Medical School..[1] Her research focuses on RNA, RNA alternative 2 and 3-dimensional structures, and alternative splicing of RNA.[2] Rouskin is well known for developing the DMS-MaPseq and DREEM methods, and for modeling the secondary structure of SARS-CoV-2 [3] [4] [5]

Early life and education

[edit]

Rouskin was born in People's Republic of Bulgaria. Her parents were rock musicians, who made most of their career in Norway. Rouskin was raised by her grandparents until age six. As the Bulgarian communist regime collapsed in 1991, she moved to the state of Idaho in 1998 for her high-school junior year, as part of a student exchange program with the USA. [6]

At 16 years old, Rouskin passed the General Educational Development and enrolled in the Florida Institute of Technology as a freshman, where she obtained a BS in Physics.

After being a technical assistant at Joe DeRisi's lab, Rouskin completed her Ph.D. in Biochemistry and Molecular Biology in 2014 at UCSF School of Medicine.[7]

Career

[edit]

In 2015, Rouskin became a Whitehead Fellow at the Whitehead Institute, a non-profit institute located in Massachusetts Institute of Technology.[8]

She is an Assistant Professor at Harvard Medical School since 2021.[9]

Selected awards

[edit]

Selected publications

[edit]

See also

[edit]

References

[edit]
  1. ^ "Faculty". micro.hms.harvard.edu.
  2. ^ "ROUSKIN LAB". ROUSKIN LAB.
  3. ^ https://www.nature.com/articles/s41467-022-28603-2
  4. ^ Zubradt, Meghan; Gupta, Paromita; Persad, Sitara; Lambowitz, Alan M.; Weissman, Jonathan S.; Rouskin, Silvi (January 30, 2017). "DMS-MaPseq for genome-wide or targeted RNA structure probing in vivo". Nature Methods. 14 (1): 75–82. doi:10.1038/nmeth.4057. PMC 5508988. PMID 27819661.
  5. ^ Tomezsko, P. J.; Corbin, V.; Gupta, P.; Swaminathan, H.; Glasgow, M.; Persad, S.; Edwards, M. D.; McIntosh, L.; Papenfuss, A. T.; Emery, A.; Swanstrom, R.; Zang, T.; Lan, T. C.; Bieniasz, P.; Kuritzkes, D. R.; Tsibris, A.; Rouskin, S. (2020). "Determination of RNA structural diversity and its role in HIV-1 RNA splicing - PMC". Nature. 582 (7812): 438–442. Bibcode:2020Natur.582..438T. doi:10.1038/s41586-020-2253-5. PMC 7310298. PMID 32555469.
  6. ^ "Silvi Rouskin: Exploring Life's Non-Linear Paths". Whitehead Institute of MIT.
  7. ^ a b "Silvi Rouskin". Vilcek Foundation.
  8. ^ "Whitehead in NYC with Fellows Olivia Corradin and Silvi Rouskin". whitehead542.rssing.com.
  9. ^ "Two Whitehead Fellows named to MIT and Harvard faculties". Whitehead Institute of MIT.
  10. ^ https://hria.org/wp-content/uploads/2016/02/Alumni_Directory_1992-2021.pdf
  11. ^ "Two students win Weintraub Awards". cmp.ucsf.edu.
  12. ^ http://www.bwfund.org/wp-content/uploads/2020/11/BWF-2018-Annual-Report_v15.pdf
  13. ^ https://www.pewtrusts.org/en/projects/pew-biomedical-scholars/directory-of-pew-scholars/2024/silvi-rouskin